Higher plants represent a rich source of new molecules with pharmacological properties, which could become lead compounds for the development of new drug products. During the last decades, the renewed interest in investigating natural substances has led to the introduction of several
important drugs, such as the anticancer substances vinblastine, vincristine, taxol and camptothecine derivatives, or the antimalarial agent artemisinin. Despite recent scientific and technological advances, parasitic diseases continue to affect millions of people in both tropical and subtropical
zones of the world. On the other hand the drugs used for the treatment of most parasitic diseases are extremely limited. In this field, natural products constitute a reservoir of new molecules with potential therapeutic interest. An outline is presented here of some important results obtained
by the Laboratory of Pharmacognosy and Phytochemistry of the University of Geneva on plants used to treat some of the neglected diseases. The strategy employed for the study of these plants is outlined, covering all aspects from the selection of plant material to the isolation of the active
substances. Different bioactivities have been investigated such as the search for new molluscicidal and larvicidal agents. Results are also included for antileishimanial and antimalarial compounds.
No Supplementary Data.
No Article Media
Document Type: Research Article
June 1, 2005
More about this publication?
International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions
CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites